Learn about PNOC's research and clinical trials for DIPG / DMG, ATRT, Medulloblastoma, Ependymoma & Craniopharyngioma, as well as immunotherapy for high grade tumors.
Pediatric brain cancer is the most deadly childhood cancer.
The Pacific Pediatric Neuro-oncology Consortium (PNOC) brings 225 clinicians and researchers together to push for breakthroughs.
PNOC is a consortium with a global presence with study sites in the United States, Canada, Australia, New Zealand, Switzerland, The Netherlands, Israel and India.
PNOC is developing clinical trials for the deadliest pediatric brain cancers and has dedicated working groups for Diffuse Midline Glioma/High grade Glioma/DIPG, Low grade Glioma, Medulloblastoma, Atypical Teratoid Rhabdoid Tumors (ATRT), Craniopharyngioma, Ependymoma, Germ Cell Tumors as well as Immunotherapy, Imaging, and DEI (Diversity, Equity, and Inclusion).
Our doctors are disruptors and thoughtful innovators who take on highly ambitious, high-yield research.
These children can't wait. By raising critical research funds for the PNOC Consortium, we at the PNOC Foundation are determined to improve outcomes for children with brain cancer.
VISION
At the Pacific Pediatric Neuro-Oncology Consortium Foundation, our vision is to lose no child to brain cancer, and to improve the quality of life for those fighting and surviving pediatric brain cancer.
MISSION
To raise resources and influence to support the PNOC Consortium as they provide access to personalized treatment strategies and ultimately improve overall outcomes for children with brain tumors.
COLLABORATIVE
PNOC’s approach is open source and global, and is making research accessible in real time, something never before seen in this field.
BY THE NUMBERS
4,800
children are diagnosed each year, of whom more than 500 will die.
28,000
children estimated to be living with a brain tumor in the U.S.
47,000
years of life lost each year to pediatric brain cancer.
1%
despite these staggering statistics, pediatric brain cancer only receives ~1% of federal research funding.
